Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.
Jason R. Gotlib
Advertisement
Articles by Jason R. Gotlib
Jason R. Gotlib discusses the research being done at his institution. Gotlib is a 2015 MPN Hero in the category of Commitment to the Individual and is also an international leader in MPN research.
Advertisement
Latest Updated Articles
Jason R. Gotlib Discusses MPN Research at StanfordDecember 22nd 2015
Advertisement
Advertisement
Trending on CURE
1
Lynch Syndrome: Why Upper Endoscopies and Colonoscopy Prep Save My Life
2
Top 5 Takeaways From ASCO 2026 That Patients Should Know
3
Iza-Bren Improves Survival in Metastatic Triple-Negative Breast Cancer
4
FDA Approves Cavhanza for PH-positive Chronic Myeloid Leukemia
5